SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-13-006110
Filing Date
2013-02-05
Accepted
2013-02-05 16:02:44
Documents
7
Period of Report
2013-03-28
Effectiveness Date
2013-02-05

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A v333955_def14a.htm DEF 14A 695578
2 GRAPHIC image_001.jpg GRAPHIC 353519
3 GRAPHIC image_002.jpg GRAPHIC 191952
4 GRAPHIC image_003.jpg GRAPHIC 173079
5 GRAPHIC image_004.jpg GRAPHIC 215921
6 GRAPHIC image_005.jpg GRAPHIC 140885
7 GRAPHIC image_006.jpg GRAPHIC 85111
  Complete submission text file 0001144204-13-006110.txt   2296357
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 13573957
SIC: 2834 Pharmaceutical Preparations